Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-12

Clinical Trial Update: Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1 [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 trial evaluating buprenorphine maintenance dosing schedules and treatment settings for opioid-related disorders; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • buprenorphine (buprenorphine)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Opioid-Related Disorders, Substance-Related Disorders | Phase 2 | Status: COMPLETED